TCG Opportunity III GP, LLC
CIK 1932445 · last filed 2026-02-12
TCG Opportunity III GP, LLC is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing shows the insider sold $24.3M of TNYA on Feb 12, 2026. Across all open-market trades the lifetime net is +$353.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $40.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$40.78M
4
12
$353.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNYA | 10%+ Owner | 4,253,298 | $0.71 | $3.03M | $38.45M | 3 | 2026-02-12 |
| EIKN | 10%+ Owner | 4,312,139 | $8.75 | $37.73M | $304.96M | 1 | 2026-02-09 |
| SRZNW | 10%+ Owner | 989,893 | $0.02 | $17.9K | $6.27M | 2 | 2026-01-08 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 0 | $1.54 | $0 | $3.45M | 6 | 2024-04-08 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | TNYA | Sell (S) | −35,202,320 | -$24.34M | EDGAR |
| 2026-02-09 | EIKN | Mixed | +45,704,800 | $304.96M | EDGAR |
| 2026-01-08 | SRZNW | Buy (P) | +105,700 | $2.10M | EDGAR |
| 2025-12-08 | SRZNW | Buy (P) | +216,900 | $4.17M | EDGAR |
| 2024-04-08 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Mixed | −21,742,413 | $0 | EDGAR |
| 2024-02-14 | TNYA | Buy (P) | +13,333,332 | $60.00M | EDGAR |
| 2023-11-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +45,262 | $31.0K | EDGAR |
| 2023-01-19 | TNYA | Buy (P) | +1,110,906 | $2.79M | EDGAR |
| 2023-01-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +10,756 | $53.2K | EDGAR |
| 2023-01-12 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +618,140 | $2.96M | EDGAR |